Skip to content

Comparison Study of Wound Closure at Time of Cesarean Delivery: Dermabond Glue Versus Surgical Staples

A Comparative Study of Closure Techniques After Cesarean Section: Staples vs. Dermabond

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00524511
Enrollment
136
Registered
2007-09-03
Start date
2007-09-30
Completion date
2012-05-31
Last updated
2013-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section

Keywords

cesarean, wound, Dermabond, superglue, staples, wound complications

Brief summary

Women who have a cesarean delivery have a surgical incision on their abdomen (belly). The usual way to close this opening is with metal surgical staples. In many other types of surgery, surgical incisions are closed with a super-glue called Dermabond. The researchers at the University of Massachusetts believe Dermabond may be a safe alternative to using staples at the time of a cesarean delivery, but this has not been studied. Women who choose to participate will be randomly assigned to have the cesarean delivery skin incision closed with staples or Dermabond. The researchers will survey the patients to see how they felt about the experience and the appearance of their scar. The researchers will survey physicians performing the surgery to see how easy Dermabond was to use. The researchers will ask physicians to evaluate the appearance of the incision after a 6-week recovery period and will analyze complications (such as bruising, infection, or separation of the wound) in the two groups.

Interventions

DEVICESurgical skin staples

Standard method to close abdominal surgical wounds

DEVICEDermabond

Alternative method (superglue) to close abdominal surgical wounds

Sponsors

University of Massachusetts, Worcester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Pregnant women undergoing scheduled and non-scheduled cesarean deliveries

Exclusion criteria

* Prisoners * Insulin-requiring diabetics * Vertical skin incision * Allergy to Dermabond

Design outcomes

Primary

MeasureTime frameDescription
Wound Complication Ratewithin six weeks of study interventionWound seroma or hematoma, wound separation, wound requiring packing, cellulitis, required extra medical clinic visits to evaluate wound

Secondary

MeasureTime frameDescription
Patient Satisfaction of Cosmesis of Surgical Woundbefore hospital discharge after surgerysurvey questionnaire using a visual analog scale to inquire about incision appearance, satisfaction with method of closure and comparison to previous closure type (if applicable)

Countries

United States

Participant flow

Recruitment details

September 4, 2007-July 9, 2010 Recruitment occured in the medical clinics and Labor and Delivery unit of an academic medical center

Pre-assignment details

The study design dictates that patients be enrolled upon admission to Labor and Delivery. Subsequently, patients who did not deliver by cesarean delivery would be excluded

Participants by arm

ArmCount
Group Receiving Alternative Skin Closure Method (Dermabond)
Women receiving Dermabond for skin closure
68
Group Receiving Standard Skin Closure Method (Surgical Staples
Women receiving standard surgical skin staples
68
Total136

Baseline characteristics

CharacteristicGroup Receiving Alternative Skin Closure Method (Dermabond)Group Receiving Standard Skin Closure Method (Surgical StaplesTotal
Age, Categorical
<=18 years
1 Participants0 Participants1 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
67 Participants68 Participants135 Participants
Sex: Female, Male
Female
68 Participants68 Participants136 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 680 / 68
serious
Total, serious adverse events
0 / 680 / 68

Outcome results

Primary

Wound Complication Rate

Wound seroma or hematoma, wound separation, wound requiring packing, cellulitis, required extra medical clinic visits to evaluate wound

Time frame: within six weeks of study intervention

Population: No participants were analyzed due to poor enrollment, subjects lost to follow-up and incomplete/partial data.

Secondary

Patient Satisfaction of Cosmesis of Surgical Wound

survey questionnaire using a visual analog scale to inquire about incision appearance, satisfaction with method of closure and comparison to previous closure type (if applicable)

Time frame: before hospital discharge after surgery

Population: No participants were analyzed due to poor enrollment, subjects lost to follow-up and incomplete/partial data.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026